Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000864493 | SCV001005300 | likely benign | Familial hypercholesterolemia | 2023-10-30 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000864493 | SCV001359442 | likely benign | Familial hypercholesterolemia | 2019-06-30 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001201282 | SCV001372401 | likely benign | not specified | 2020-06-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002381929 | SCV002700978 | likely benign | Cardiovascular phenotype | 2022-04-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV004002946 | SCV004820306 | likely benign | Hypercholesterolemia, familial, 1 | 2023-12-13 | criteria provided, single submitter | clinical testing | |
GENin |
RCV000864493 | SCV005441722 | likely benign | Familial hypercholesterolemia | 2024-09-27 | criteria provided, single submitter | clinical testing | This is a synonymous (silent) variant that is not predicted to impact splicing and occurs at a nucleotide which is not conserved. Therefore this variant has been classified as Likely Benign (BP4, BP7). |
Natera, |
RCV000864493 | SCV002086419 | likely benign | Familial hypercholesterolemia | 2021-02-16 | no assertion criteria provided | clinical testing |